33817-20-8 Usage
Description
Pivampicillin is a semi-synthetic antibiotic derived from the penicillin group. It is a white or almost white, crystalline powder with potent antibacterial properties. Pivampicillin is known for its effectiveness in treating various bacterial infections and has been associated with sensitization and contact dermatitis in some individuals, particularly those working in the pharmaceutical production industry.
Uses
Used in Pharmaceutical Industry:
Pivampicillin is used as an antibiotic for the treatment of bacterial infections. Its application is primarily due to its ability to inhibit bacterial cell wall synthesis, leading to the destruction of the bacterial cell. It is effective against a wide range of gram-positive and some gram-negative bacteria, making it a versatile choice for various infections.
Additionally, Pivampicillin may be used in the development of new drug delivery systems to enhance its efficacy and bioavailability, similar to the applications of Gallotannin in the field of anticancer treatments. This could involve the use of organic or metallic nanoparticles as carriers for improved delivery and therapeutic outcomes.
Therapeutic Function
Antibacterial
Check Digit Verification of cas no
The CAS Registry Mumber 33817-20-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,3,8,1 and 7 respectively; the second part has 2 digits, 2 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 33817-20:
(7*3)+(6*3)+(5*8)+(4*1)+(3*7)+(2*2)+(1*0)=108
108 % 10 = 8
So 33817-20-8 is a valid CAS Registry Number.
InChI:InChI=1/C22H29N3O6S/c1-21(2,3)20(29)31-11-30-19(28)15-22(4,5)32-18-14(17(27)25(15)18)24-16(26)13(23)12-9-7-6-8-10-12/h6-10,13-15,18H,11,23H2,1-5H3,(H,24,26)/t13-,14-,15+,18-/m1/s1
33817-20-8Relevant articles and documents
Method of using deuterated calcium channel blockers
-
, (2008/06/13)
Therapeutic methods and compositions using deuterated enriched 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylic acid 3-ethyl 5-methyl ester and other deuterated dihydropyridine compounds are described. The deuterated compounds exhibit enhanced efficacy in blocking calcium channels over non-deuterated dihydropyridines.
Crystalline pivaloyloxymethyl d(-)-α-aminobenzylpenicillinate
-
, (2008/06/13)
The present invention relates to pivaloyloxymethyl D(-)-α-aminobenzylpenicillinate of the formula I in a novel and improved form, i.e. the crystalline form SPC1 To methods of producing said crystalline pivaloyloxymethyl D(-)-α-aminobenzylpenicillinate and to pharmaceutical preparations containing said crystalline pivaloyloxymethyl D(-)-α-aminobenzylpenicillinate. Crystalline pivaloyloxymethyl D(-)-α-aminobenzylpenicillinate has no bitter taste, is only slightly soluble in water, and is stable and readily absorbable.